ArticleMolecular cancer therapeutics2022

Adoptive Transfer of Anti-Nucleolin T Cells Combined with PD-L1 Inhibition against Triple-Negative Breast Cancer.

Suyanee Thongchot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.